Lutetium-177 PSMA-directed endoradiotherapy

Lutetium-177-PSMA · Endocyte

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lutetium-177 PSMA-directed endoradiotherapy, covering 2021-03-24 to 2021-03-24. Get the full timeline:

Most recent: Clinical Trial Update: Lutetium-177 (Lu177) Prostate-Specific Antigen (PSMA)-Directed EndoRadiotherapy [Phase 2]